IMMIX BIOPHARMA, INC. (IMMX)

13.91USD +0.58% (+0.08)

Over 1M: +43.1%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

10 12 14
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Income: -348K Q3 '21 — Free Cash Flow: -50.8K Q4 '21 — Operating Income: -598.3K Q4 '21 — Free Cash Flow: -1.1M Q1 '22 — Operating Income: -1.3M Q2 '22 — Operating Income: -1.6M Q3 '22 — Operating Income: -1.5M Q4 '22 — Operating Income: -3.8M Q1 '23 — Operating Income: -2.5M Q2 '23 — Operating Income: -3.7M Q3 '23 — Operating Income: -4.5M Q4 '23 — Operating Income: -5.4M Q4 '23 — Free Cash Flow: -2.7M Q1 '24 — Operating Income: -5.6M Q1 '24 — Free Cash Flow: -4.1M Q2 '24 — Operating Income: -4.7M Q2 '24 — Free Cash Flow: -5.4M Q3 '24 — Operating Income: -7.4M Q3 '24 — Free Cash Flow: -4.3M Q4 '24 — Operating Income: -5M Q4 '24 — Free Cash Flow: -2M Q1 '25 — Operating Income: -4.7M Q1 '25 — Free Cash Flow: -1.8M Q2 '25 — Operating Income: -6.7M Q2 '25 — Free Cash Flow: -5.4M Q3 '25 — Operating Income: -7.7M Q3 '25 — Free Cash Flow: -6.3M Q4 '25 — Operating Income: -10.9M Q4 '25 — Free Cash Flow: -11.2M Q1 '26 — Operating Income: -10.8M Q1 '26 — Free Cash Flow: -9.9M Q2 '26 — Operating Income: -12.5M Q2 '26 — Free Cash Flow: -11.8M -10M -7.5M -5M -2.5M 0
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Income Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
Accruals -0.59%
ROA -16.7%
ROCE -18.2%
ROE -17.4%
Asset turnover —
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —
SBC / sales —

0 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
EV/OE -18.3×
P/C 4.3×
P/B 4.3×
FCF yield -3.9%
Div. yield —
EV/EBIT —
EV/GP —
EV/Sales —
Fwd P/E —
P/E —
PEG —

1 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
Current ratio 25.1×
ND/EBITDA 0.3
Interest cover -84136.8×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 25.1×
Cash runway 5.9 yr
Cash / Debt —
F-score —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

0.5
Shares change +16.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Sales/sh Y/Y —

0 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.